Calcimimetic Compounds: a Direct Approach to Controlling Plasma Levels of Parathyroid Hormone in Hyperparathyroidism
- 1 March 1999
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 10 (2) , 66-71
- https://doi.org/10.1016/s1043-2760(98)00119-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Treatment of Hypercalcemia Secondary to Parathyroid Carcinoma with a Novel Calcimimetic AgentJournal of Clinical Endocrinology & Metabolism, 1998
- Calcimimetics in actionKidney International, 1998
- NPS R-568 halts or reverses osteitis fibrosa in uremic ratsKidney International, 1998
- The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor.Journal of Clinical Investigation, 1997
- Short-Term Inhibition of Parathyroid Hormone Secretion by a Calcium-Receptor Agonist in Patients with Primary HyperparathyroidismNew England Journal of Medicine, 1997
- Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidismKidney International, 1997
- Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor geneEndocrinology, 1995
- The pathogenesis of parathyroid gland hyperplasia in chronic renal failureKidney International, 1995
- Comparison of Intermittent and Continuous Oral Administration of Calcitriol in Dialysis Patients: A Randomized Prospective TrialNephron, 1994
- Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroidNature, 1993